EMA — authorised 4 February 1998
- Marketing authorisation holder: Boehringer Ingelheim International GmbH
- Status: approved
🇪🇺 Viramune in European Union
EMA authorised Viramune on 4 February 1998
Marketing authorisation
Viramune in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Viramune approved in European Union?
Yes. EMA authorised it on 4 February 1998.
Who is the marketing authorisation holder for Viramune in European Union?
Boehringer Ingelheim International GmbH holds the EU marketing authorisation.